FDA approves first once-daily oral cholesterol pill: How it works, who can take it, and how it compares with statins and injections
The FDA has approved Lipfendra, a new daily oral medication for high cholesterol. This drug belongs to a newer class of medicines called PCSK9 inhibitors. Lipfendra works by helping the liver remove more bad cholesterol from the blood. It offers an easier alternative for patients who previously needed injections. This approval provides a valuable new option for managing difficult cholesterol levels.
The FDA has approved Lipfendra, a new daily oral medication for high cholesterol. This drug belongs to a newer class of medicines called PCSK9 inhibitors. Lipfendra works by helping the liver remove more bad cholesterol from the blood. It offers an easier alternative for patients who previously needed injections. This approval provides a valuable new option for managing difficult cholesterol levels.
